Big tobacco’s PMI makes another pharma foray with Vectura dealTobacco giant Philip Morris International (PMI) has doubled down on its move into the pharmaceutical sector, following up Share XBig tobacco’s PMI makes another pharma foray with Vectura dealhttps://pharmaphorum.com/news/big-tobaccos-pmi-makes-another-pharma-foray-with-vectura-deal/
Sonde Health partners with Qualcomm on vocal biomarker techSonde Health has joined forces with chipmaker Qualcomm to develop a technology platform that could diagnose human health Share XSonde Health partners with Qualcomm on vocal biomarker techhttps://pharmaphorum.com/news/sonde-health-partners-with-qualcomm-on-vocal-biomarker-tech/
Vectura agrees $1.4bn takeover by private equity group CarlyleVectura has agreed to a £1.55 per share takeover by US private investment company Carlyle, which values the Share XVectura agrees $1.4bn takeover by private equity group Carlylehttps://pharmaphorum.com/news/vectura-agrees-1-4bn-takeover-by-private-equity-group-carlyle/
FDA extends tie-up with CN Bio to test ‘lung-on-a-chip’ techThe FDA has extended a collaboration with the UK firm CN Bio to investigate a “lung-on-a-chip” model to Share XFDA extends tie-up with CN Bio to test ‘lung-on-a-chip’ techhttps://pharmaphorum.com/news/fda-extends-tie-up-with-cn-bio-to-test-lung-on-a-chip-tech/
UK data hub to apply AI to health records for COVID-19 and respiratory researchHealth Data Research UK’s respiratory hub BREATHE is set to use artificial intelligence (AI) to unlock real-world insights Share XUK data hub to apply AI to health records for COVID-19 and respiratory researchhttps://pharmaphorum.com/news/uk-data-hub-breathe-ai-savana/
COVID cough app Hyfe launches in UK and IrelandA smartphone app that uses artificial intelligence to assess the sound of coughing has been launched in the Share XCOVID cough app Hyfe launches in UK and Irelandhttps://pharmaphorum.com/news/covid-cough-app-hyfe-launches-in-uk-and-ireland/
AstraZeneca breathes sigh of relief as court blocks US Symbicort genericA US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper competition for the ageing Share XAstraZeneca breathes sigh of relief as court blocks US Symbicort generichttps://pharmaphorum.com/news/astrazeneca-breathes-sigh-of-relief-as-court-blocks-us-symbicort-generic/
AZ trumpets tezepelumab data as filing for severe asthma loomsAstraZeneca says full data from the NAVIGATOR trial of tezepelumab in severe asthma keep it on course to Share XAZ trumpets tezepelumab data as filing for severe asthma loomshttps://pharmaphorum.com/news/az-trumpets-tezepelumab-data-as-filing-for-severe-asthma-looms/
Boost for Verona Pharma after trial win with inhaled COPD drugUK-based Verona Pharma has scored a new win with its chronic obstructive pulmonary disease (COPD) drug ensifenitrine, after Share XBoost for Verona Pharma after trial win with inhaled COPD drughttps://pharmaphorum.com/news/verona-pharma-scores-trial-win-with-inhaled-copd-drug/
